RxDoctor Payments Data

Jeffrey Sims

Psychiatric/Mental Health · Cleveland, OHNPI 1104206796

Payments from drug & device makers

$874in general payments, 2019–2025

Across 44 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$235
  • Indivior Inc.$160
  • Lundbeck LLC$101
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$86
  • Sunovion Pharmaceuticals Inc.$76
  • Johnson & Johnson$65
  • plus $151 from 4 others

What the payments were for

  • Food & beverage$84797%
  • Education$273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$874 in reported general payments places this provider in the 55th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$7,671
Medicare patients
18
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate23$58,817
VraylarCariprazine Hcl26$37,181
Abilify MaintenaAripiprazole13$33,679
CaplytaLumateperone Tosylate11$18,379
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl155$14,040
Aripiprazole94$7,297
Paliperidone ErPaliperidone43$7,110
TrintellixVortioxetine Hydrobromide14$6,015
Olanzapine83$5,821
Clozapine40$5,695
Lurasidone Hcl32$3,225
Quetiapine Fumarate100$2,380
Fluphenazine Hcl12$2,156
Fluphenazine Decanoate13$1,566
Ziprasidone Hcl31$1,512

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$65$58,81723 claims
AbbVieVraylar$235$37,18126 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$86$18,37911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →